| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| January 14, 2011 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,499 | -- | 2,500 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $1,197.80 | 12 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,999 | -- | 5,000 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 83 | $1,197.80 | 83 | |
| January 14, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 34,583 | -- | 34,583 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $1,197.80 | 41 | |
| January 14, 2011 | CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,083 | -- | 17,083 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 8 | $1,197.80 | 8 | |
| January 14, 2011 | Controller & CAO | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,333 | -- | 3,333 | |
| December 6, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | $2.81 | 30,000 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,550 | $3.03 | 28,087 | |
| September 22, 2010 | Chief Medical Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 100 | $3.04 | 28,187 | |
| September 16, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $3.10 | 15,000 | |
| August 10, 2010 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,000 | $3.35 | 3,000 | |
| July 29, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | $3.42 | 30,000 | |
| July 6, 2010 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 25,000 | |
| July 6, 2010 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | $3.39 | 100,000 | |
| May 7, 2010 | President & CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $3.95 | 126,662 | |
| April 13, 2010 | Interim Chief Accounting Off. | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 700 | -- | 7,700 | |
| April 13, 2010 | Interim Chief Accounting Off. | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 700 | -- | 21,400 | |
| February 19, 2010 | Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,537 | $2.94 | 26,537 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
